Skip to main content
Livermore
Livermore
ZHEN

Pharvaris N.V.

PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001830487

In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q1 2025

Institutional positions in Pharvaris N.V. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
−2 vs. Q4 2024
Shares held
44.9M
+294.9K (+0.7%) vs. Q4 2024
Total value
$705.5M
−$150.3M (−17.6%) vs. Q4 2024
New holders
3
15 more added
Sold out
5
14 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 52 institutions
Q1 2021: 33 institutionsQ2 2021: 28 institutionsQ3 2021: 25 institutionsQ4 2021: 22 institutionsQ1 2022: 22 institutionsQ2 2022: 20 institutionsQ3 2022: 21 institutionsQ4 2022: 25 institutionsQ1 2023: 21 institutionsQ2 2023: 21 institutionsQ3 2023: 21 institutionsQ4 2023: 36 institutionsQ1 2024: 35 institutionsQ2 2024: 36 institutionsQ3 2024: 51 institutionsQ4 2024: 54 institutionsQ1 2025: 52 institutionsQ2 2025: 60 institutionsQ3 2025: 83 institutionsQ4 2025: 106 institutionsQ1 2026: 110 institutionsQ2 2026: 125 institutions
Value heldQ1 2025: $705.5M
Q1 2021: $616.5MQ2 2021: $406.3MQ3 2021: $380.3MQ4 2021: $321.1MQ1 2022: $397.1MQ2 2022: $494.0MQ3 2022: $173.6MQ4 2022: $239.6MQ1 2023: $173.9MQ2 2023: $441.6MQ3 2023: $606.6MQ4 2023: $1.14BQ1 2024: $980.5MQ2 2024: $808.6MQ3 2024: $834.2MQ4 2024: $855.8MQ1 2025: $705.5MQ2 2025: $792.7MQ3 2025: $1.44BQ4 2025: $1.64BQ1 2026: $1.67BQ2 2026: $2.23B
Institutions holding PHVS and their total value by quarter
QuarterHoldersValue
Q2 2026125$2.23B
Q1 2026110$1.67B
Q4 2025106$1.64B
Q3 202583$1.44B
Q2 202560$792.7M
Q1 202552$705.5M
Q4 202454$855.8M
Q3 202451$834.2M
Q2 202436$808.6M
Q1 202435$980.5M
Q4 202336$1.14B
Q3 202321$606.6M
Q2 202321$441.6M
Q1 202321$173.9M
Q4 202225$239.6M
Q3 202221$173.6M
Q2 202220$494.0M
Q1 202222$397.1M
Q4 202122$321.1M
Q3 202125$380.3M
Q2 202128$406.3M
Q1 202133$616.5M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q4 2024.

Institutions holding PHVS in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Amundi1$150.00%−142−99.3%Reduced
SBI Securities Co., Ltd.1$160.00%−10−90.9%Reduced
BNP Paribas Arbitrage, SA158$2.48K0.00%+58+58.0%Added
Citigroup Inc543$8.53K0.00%00.0%Unchanged
Wells Fargo & Company950$14.9K0.00%+150+18.8%Added
Cubist Systematic Strategies, LLC2,278$35.8K0.00%−1,058−31.7%Reduced
Police & Firemen's Retirement System of New Jersey2,369$37.2K0.00%00.0%Unchanged
JPMorgan Chase & Co2,559$40.2K0.00%−541−17.5%Reduced
Barclays PLC2,861$44.9K0.00%−3−0.1%Reduced
Public Employees Retirement System of Ohio4,500$70.7K0.00%+1,000+28.6%Added
KLP Kapitalforvaltning AS5,800$91.1K0.00%00.0%Unchanged
UBS Group AG7,449$116.9K0.00%+6,404+612.8%Added
Virtus Investment Advisers, Inc.8,636$135.6K0.04%+8,636New
Legal & General Group Plc9,855$154.7K0.00%00.0%Unchanged
Vanguard Group Inc12,740$200.0K0.00%00.0%Unchanged
California State Teachers Retirement System12,791$200.8K0.00%−635−4.7%Reduced
Palumbo Wealth Management LLC14,102$221.4K0.07%+3,881+38.0%Added
HighVista Strategies LLC22,768$357.5K0.14%00.0%Unchanged
Swiss National Bank26,257$412.2K0.00%00.0%Unchanged
Deutsche Bank AG28,174$442.3K0.00%+10,006+55.1%Added
Bank of America Corp29,206$458.5K0.00%−1,602−5.2%Reduced
Alps Advisors Inc36,633$575.1K0.00%−7,038−16.1%Reduced
Geode Capital Management, LLC38,333$601.8K0.00%00.0%Unchanged
Manufacturers Life Insurance Company, The40,978$643.4K0.00%00.0%Unchanged
Point72 Asset Management, L.P.52,574$825.4K0.00%+44,653+563.7%Added
UBS Asset Management Americas Inc68,331$1.07M0.00%+4,597+7.2%Added
Morgan Stanley75,365$1.18M0.00%+48,368+179.2%Added
TD Asset Management Inc78,122$1.23M0.00%+22,906+41.5%Added
Northern Trust Corp86,876$1.36M0.00%−5,056−5.5%Reduced
State Street Corp93,784$1.47M0.00%+1,778+1.9%Added
Polygon Management Ltd.126,995$1.99M0.64%+126,995New
BlackRock, Inc.192,865$3.03M0.00%−1,330−0.7%Reduced
Rosalind Advisors, Inc.223,627$3.51M1.71%+223,627New
Patient Square Capital LP245,496$3.85M1.59%+37,893+18.3%Added
Sphera Funds Management Ltd.383,856$6.03M1.49%−4,327−1.1%Reduced
Price T Rowe Associates Inc586,087$9.20M0.00%+142,191+32.0%Added
Sofinnova Investments, Inc.593,403$9.32M0.70%+32,680+5.8%Added
Rock Springs Capital Management LP623,402$9.79M0.56%−151,729−19.6%Reduced
Octagon Capital Advisors LP769,815$12.1M2.63%−8,185−1.1%Reduced
5AM Venture Management, LLC797,600$12.5M4.74%00.0%Unchanged
Soleus Capital Management, L.P.814,652$12.8M1.00%00.0%Unchanged
Cormorant Asset Management, LP1,466,460$23.0M1.74%00.0%Unchanged
Novo Holdings A/S1,725,000$27.1M2.06%00.0%Unchanged
Commodore Capital LP1,911,433$30.0M2.21%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)2,017,464$31.7M0.63%00.0%Unchanged
VR Adviser, LLC3,112,720$48.9M4.16%−107,410−3.3%Reduced
Bain Capital Life Sciences Investors, LLC3,303,381$51.9M7.67%00.0%Unchanged
Viking Global Investors LPSuperinvestorViking Global Investors3,653,310$57.4M0.18%00.0%Unchanged
venBio Partners LLC4,289,304$67.3M54.50%00.0%Unchanged
Foresite Capital Management IV, LLC4,410,581$69.2M62.35%+12,700+0.3%Added
FMR LLC5,395,370$84.7M0.01%00.0%Unchanged
General Atlantic LLC7,531,252$118.2M3.97%00.0%Unchanged
Woodline Partners LP0$00.00%−44,514−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−44,247−100.0%Sold out
HealthInvest Partners AB0$00.00%−34,328−100.0%Sold out
Millennium Management LLC0$00.00%−17,731−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−3,738−100.0%Sold out